VVOS compared with NXXT: revenue, margins and what each company keeps, and the suppliers and customers both name

VVOSVivos Therapeutics, Inc.

Mkt capRevenueRevenue

NXXTNextnrg, Inc.

Mkt capRevenueRevenue

Compare

VVOSVivos Therapeutics, Inc.

NXXTNextnrg, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

VVOS

No earnings history for VVOS.

NXXT

Reportimpliedrealized× implied

Q2 FY26—▼−17.04%—

May 18 '26—▲+46.22%—

Q1 FY26—▼−19.93%—

Nov 17 '25—▼−32.14%—

= impliedVVOS realized, solidNXXT realized, hatchedOne scale, both sides: full bar = 47%× = |realized| ÷ impliedSource: market data

VVOSVivos Therapeutics, Inc.

0.09▼−9.36%· post 0.10

Mkt cap$1.9MRevenue$5MQ2 FY26Revenue$17MFY25

NXXTNextnrg, Inc.

2.30▼−1.29%· post 2.65

ClosedNov 6 '26

Mkt cap$3.9MRevenue$28MQ2 FY26Revenue—

Compare

ClosedNov 6 '26

VVOSVivos Therapeutics, Inc.

NXXTNextnrg, Inc.

0.09▼−9.36%post 0.10

Price

2.30▼−1.29%post 2.65

$1.9M

Mkt cap

$3.9M

Q2 FY26$5M

Revenue

$28MQ2 FY26

FY25$17M

Revenue

—

VVOS0.09▼−9.36%vsNXXT2.30▼−1.29%ClosedNov 6 '26